K
0.501
0.01 (2.24%)
| Penutupan Terdahulu | 0.490 |
| Buka | 0.510 |
| Jumlah Dagangan | 766,638 |
| Purata Dagangan (3B) | 1,495,409 |
| Modal Pasaran | 36,340,896 |
| Harga / Buku (P/B) | 3.66 |
| Julat 52 Minggu |
| EPS Cair (TTM) | -0.270 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 276.80% |
| Nisbah Semasa (MRQ) | 0.290 |
| Aliran Tunai Operasi (OCF TTM) | -4.48 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -1.95 M |
| Pulangan Atas Aset (ROA TTM) | -151.41% |
| Pulangan Atas Ekuiti (ROE TTM) | -1,544.44% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | Klotho Neurosciences, Inc. | - | - |
AISkor Stockmoo
-1.0
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -2.0 |
| Purata | -1.00 |
|
Klotho Neurosciences Inc is in the development of patented, novel disease-modifying technologies targeting the brain and central nervous system (CNS) that are seen as key developments in treating neurodegenerative and age-related disorders. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| % Dimiliki oleh Orang Dalam | 50.23% |
| % Dimiliki oleh Institusi | 2.60% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Arkadios Wealth Advisors | 30 Sep 2025 | 25,000 |
| Sg Americas Securities, Llc | 30 Sep 2025 | 11,949 |
| Gabelli & Co Investment Advisers, Inc. | 30 Sep 2025 | 10,000 |
| Ep Wealth Advisors, Llc | 30 Jun 2025 | 10,000 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 07 Nov 2025 | Pengumuman | Klotho Neurosciences Wins the 2025 BioTech Breakthrough 'Cell Therapy Innovation of the Year' Award |
| 16 Oct 2025 | Pengumuman | Klotho Neurosciences CEO to Attend Longevity Biotech 2025 in Boston |
| 07 Oct 2025 | Pengumuman | Klotho Neurosciences Announces Expiration of Letter of Intent |
| 30 Sep 2025 | Pengumuman | Klotho Neurosciences Signs Letter of Intent to Acquire Select Assets from Turn Biotechnologies, Anchored by $300 Million Global Pharma Partnership |
| 08 Sep 2025 | Pengumuman | Klotho Neurosciences CEO to Attend Inaugural Conference & Scientific Seminar |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |